Screener
MoonLake Immunotherapeutics MLTX PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 8:55 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001821586-26-000007
| (in thousands, except share and per share data) | March 31, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| Total current assets | 396,641 | 421,694 |
| Non-current assets | ||
| Operating lease right-of-use assets | 1,857 | 1,566 |
| Property and equipment, net | 532 | 577 |
| Other non-current assets | 1,344 | 596 |
| Total non-current assets | 3,733 | 2,739 |
| Total assets | $400,374 | $424,433 |
| Liabilities and Equity |
Item 1. Financial Statements (Unaudited)
FAQ
- What is MoonLake Immunotherapeutics's PP&E (net)?
- MoonLake Immunotherapeutics (MLTX) reported PP&E (net) of $532K in Q1 2026.
- How has MoonLake Immunotherapeutics's PP&E (net) changed year-over-year?
- MoonLake Immunotherapeutics's PP&E (net) decreased by 25.2% year-over-year, from $711K to $532K.
- What is the long-term trend for MoonLake Immunotherapeutics's PP&E (net)?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's PP&E (net) has grown at a 88.5% compound annual growth rate (CAGR), from $45.74K to $577K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about MoonLake Immunotherapeutics's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude